These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25196945)

  • 1. Problems with the identification of 'problematic' cannabis use: examining the issues of frequency, quantity, and drug use environment.
    Asbridge M; Duff C; Marsh DC; Erickson PG
    Eur Addict Res; 2014; 20(5):254-67. PubMed ID: 25196945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to screen for problematic cannabis use in population surveys: an evaluation of the Cannabis Use Disorders Identification Test (CUDIT) in a Swiss sample of adolescents and young adults.
    Annaheim B; Rehm J; Gmel G
    Eur Addict Res; 2008; 14(4):190-7. PubMed ID: 18583916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring cannabis consumption: Psychometric properties of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU).
    Cuttler C; Spradlin A
    PLoS One; 2017; 12(5):e0178194. PubMed ID: 28552942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cannabis Use Problems Identification Test (CUPIT): development, reliability, concurrent and predictive validity among adolescents and adults.
    Bashford J; Flett R; Copeland J
    Addiction; 2010 Apr; 105(4):615-25. PubMed ID: 20403014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rethinking indicators of problematic cannabis use in the era of medical cannabis legalization.
    Sznitman SR; Room R
    Addict Behav; 2018 Feb; 77():100-101. PubMed ID: 28992573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of cannabis: screening strategy and evaluation of severity factors].
    Delile JM
    Rev Prat; 2005 Jan; 55(1):51-63. PubMed ID: 15801397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of problematic cannabis use in Canada: Cross-sectional findings from the 2013 Canadian Tobacco, Alcohol and Drugs Survey.
    Leos-Toro C; Rynard V; Hammond D
    Can J Public Health; 2018 Jan; 108(5-6):e516-e522. PubMed ID: 29356658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential responses to cannabis potency: a typology of users based on self-reported consumption behaviour.
    Korf DJ; Benschop A; Wouters M
    Int J Drug Policy; 2007 May; 18(3):168-76. PubMed ID: 17689363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routes of administration of cannabis used for nonmedical purposes and associations with patterns of drug use.
    Baggio S; Deline S; Studer J; Mohler-Kuo M; Daeppen JB; Gmel G
    J Adolesc Health; 2014 Feb; 54(2):235-40. PubMed ID: 24119417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis policies and user practices: market separation, price, potency, and accessibility in Amsterdam and San Francisco.
    Reinarman C
    Int J Drug Policy; 2009 Jan; 20(1):28-37. PubMed ID: 18367390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are diagnostic orphans at risk of developing cannabis abuse or dependence? Four-year follow-up of young adult cannabis users not meeting diagnostic criteria.
    Degenhardt L; Coffey C; Carlin JB; Swift W; Patton GC
    Drug Alcohol Depend; 2008 Jan; 92(1-3):86-90. PubMed ID: 17716830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco, alcohol, cannabis and other illegal drug use among young adults: the socioeconomic context.
    Redonnet B; Chollet A; Fombonne E; Bowes L; Melchior M
    Drug Alcohol Depend; 2012 Mar; 121(3):231-9. PubMed ID: 21955362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Cannabis Expectancy Questionnaire (CEQ) in adult cannabis users in treatment.
    Connor JP; Gullo MJ; Feeney GF; Young RM
    Drug Alcohol Depend; 2011 Jun; 115(3):167-74. PubMed ID: 21163593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problematic alcohol and cannabis use in adolescence--risk of serious adult substance abuse?
    Stenbacka M
    Drug Alcohol Rev; 2003 Sep; 22(3):277-86. PubMed ID: 15385221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiological news in cannabis].
    Beck F; Guignard R; Richard JB
    Rev Prat; 2013 Dec; 63(10):1420-4. PubMed ID: 24579342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis-related impairment and social anxiety: the roles of gender and cannabis use motives.
    Buckner JD; Zvolensky MJ; Schmidt NB
    Addict Behav; 2012 Nov; 37(11):1294-7. PubMed ID: 22766487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age Invariance of the Cannabis Abuse Screening Test in a Probabilistic Sample of Cannabis Users.
    Legleye S; Rouquette A
    Eur Addict Res; 2018; 24(1):37-42. PubMed ID: 29495016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 'grass ceiling': limitations in the literature hinder our understanding of cannabis use and its consequences.
    Temple EC; Brown RF; Hine DW
    Addiction; 2011 Feb; 106(2):238-44. PubMed ID: 21208311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis use in a Swiss male prison: qualitative study exploring detainees' and staffs' perspectives.
    Ritter C; Broers B; Elger BS
    Int J Drug Policy; 2013 Nov; 24(6):573-8. PubMed ID: 23773686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.